Quantcast

Latest Fecal bacteriotherapy Stories

2012-02-09 07:43:57

(Ivanhoe Newswire)-- The deadly infection Clostridium difficile also known as C. difficile is known to be spread in hospitals upon contact with a C.diffile infected patient. A study is now reporting that only a small amount of cases of C.difficle are actually spread via contact from an already infected patient. These findings are important because the disease may not be controlled properly in a hospital setting using conventional strategies. In a study led by Professor Tim Peto of the...

2012-02-08 10:14:43

Contrary to current convention by which infection with the organism Clostridium difficile is regarded as an infection that is acquired by contact with symptomatic patients known to be infected with C. difficile, these may account for only a minority of new cases of the infection. These findings are important as they indicate that C. difficile infection, which can be fatal especially in older people, may not be effectively controlled by current hospital infection strategies. In a study led...

119631101
2012-01-27 09:57:03

Persistent bacterial infections can make a mess of our bowels and the usual treatment method of adding antibiotics usually causes even more disruptions. Researchers, however, are fine tuning a treatment that involves adding a sample of the stool of another which jump-starts the infected patients immune system, reports Kerry Grens for Reuters Health. The procedure is used primarily to treat patients with infections from the bacterium Clostridium difficile. “It´s unbelievably...

2011-06-02 15:56:26

The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery. Bacterial aggregates derived from fecal matter have been used sporadically to treat gastrointestinal disease for more than 50 years. These were...

2011-04-25 08:16:34

(Ivanhoe Newswire) -- Patients with inflammatory bowel disease (IBD) have a greater risk of dying if they become infected with Clostridium difficile, according to a new study. IBD, which includes Crohn's disease and ulcerative colitis, causes symptoms such as abdominal pain and diarrhea. Patients with the condition are often sent to the hospital when they experience severe symptoms. The C. difficile infection is not usually fatal in people who are not already severely ill or elderly. British...

2011-04-02 13:00:00

SAN DIEGO, April 2, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI. Investigator Erik R. Dubberke, M.D., M.S.P.H., of the Washington...

2010-10-18 16:23:57

In five different studies presented at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, researchers explored the impact of various factors on increasing rates of Clostridium difficile infection (C. difficile), such as the use of proton pump inhibitors (PPIs) and the substantial increase in antibiotic use due to new National Hospital Quality Measures; strategies to combat high rates of C. difficile infections; and cutting"edge...

2010-03-17 15:57:23

Greater understanding of genetics of ulcerative colitis key to developing new treatments, researchers say LOS ANGELES -- A study of the human genome led by Cedars-Sinai researchers has now identified genes linked to ulcerative colitis, offering clues as to what causes the condition and potential avenues for new therapies to treat the disease. The study, published in Nature Genetics, examined genes of nearly 13,000 patients to determine which parts of the genome are linked to ulcerative...

2010-02-04 15:10:00

SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related